Oncology Burst
FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer
FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer
Promoting the development of safe and effective new drugs and biologics to treat cancer in children
Take this survey powered by surveymonkey.com. Create your own surveys for free.
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
OCE experts regularly join colleagues to participate in major conferences.
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products
This installment of FDA/OCE’s Conversation on Cancer, “ODAC Chronicles—the Past, Present, and Future of Oncology Advisory Committees” will focus on the role …
List of OCE Programs and Projects and links to their webpages.
Oncology Center of Excellence professional education projects and resources – 2023 OCE Annual Report